Can we take the STING out of bone loss? Pathway presents potential treatment target for skeletal aging

Researchers have identified the STING signaling pathway as a key molecular driver of bone loss and osteoporosis during aging. As bones weaken with age, changes in the bone marrow microenvironment—including increased fat accumulation and inflammation-promoting immune cells—contribute to skeletal deterioration. By targeting the STING pathway, scientists believe they may be able to slow or prevent age-related bone loss. This discovery opens new possibilities for developing treatments to maintain bone strength and reduce fracture risk in older adults, addressing a major cause of disability and reduced quality of life.